Commercial Partners
International Technical Legacy (ITL)
International Technical Legacy (ITL) holds an exclusive five-year commercial supply agreement with Memphasys, covering 15+ countries across the Middle East and North Africa. ITL provides access to approximately 353 IVF clinics and approximately 140,000 annual IVF cycles in the region. Minimum contracted cartridge revenue: ~A$390,000. ITL placed initial orders in December 2025 and repeat orders in February 2026.
Centro Fertilità Assistita (CFA Italia)
Europe Centro Fertilità Assistita (CFA Italia) is one of Italy’s largest private fertility clinic groups. Memphasys has a five-year commercial supply agreement with CFA Italia following CE Mark approval in December 2025. Minimum contracted purchases: approximately A$925,000. Clinic onboarding is underway with expansion across further European markets.
Andro Diagnostics
India Andro Diagnostics / ACC holds a five-year non-exclusive supply agreement for India, providing access to a network of 200+ IVF clinics. Year 1 minimum: 1,800 cartridges. The agreement is pending activation upon CDSCO regulatory approval, expected approximately mid-2026.
Research & Clinical Validation Partners
The University of Newcastle
The Priority Research Centre for Reproductive Science at the University of Newcastle is the largest research group in the field of reproduction medicine and fertility in Australia, working with humans and across most animal species.
The University of Newcastle (UoN) is internationally recognised for its contribution to human reproduction and fertility. The Priority Research Centre for Reproductive Science (PRCRS) is led by Professor John Aitken, who is internationally recognised for his breakthrough research history in this field.
Monash IVF Group
Serves to support you on every step of your fertility journey
Monash was an early international pioneer in In Vitro Fertilisation (IVF), helping achieve Australia’s first IVF baby, the third in the world, in 1980.
Today Monash IVF is the second largest IVF group in Australia. MIVF is a clinical partner in Australia for Memphasys.
Monash IVF was the primary Australian clinical partner for the Memphasys Phase III randomised controlled trial of the Felix™ System. The trial has been completed, with data supporting CE Mark and TGA regulatory approvals and demonstrating superior outcomes versus density gradient centrifugation.